The price-to-earnings ratio for Xylem Inc (NYSE: XYL) is 48.82x, which is above its average ratio. Moreover, the 36-month beta value for XYL is 1.04. Analysts have varying opinions on the stock, with 7 analysts rating it as a “buy,” 3 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for XYL is 240.84M and currently, short sellers hold a 1.41% of that float. On July 30, 2024, XYL’s average trading volume was 1.26M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
XYL) stock’s latest price update
The stock price of Xylem Inc (NYSE: XYL) has plunged by -3.30 when compared to previous closing price of 141.53, but the company has seen a -2.74% decline in its stock price over the last five trading sessions. zacks.com reported 2024-07-30 that Although the revenue and EPS for Xylem (XYL) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
XYL’s Market Performance
Xylem Inc (XYL) has seen a -2.74% fall in stock performance for the week, with a 0.91% gain in the past month and a 3.22% surge in the past quarter. The volatility ratio for the week is 2.55%, and the volatility levels for the past 30 days are at 2.14% for XYL. The simple moving average for the last 20 days is -0.12% for XYL stock, with a simple moving average of 12.49% for the last 200 days.
Analysts’ Opinion of XYL
Many brokerage firms have already submitted their reports for XYL stocks, with Exane BNP Paribas repeating the rating for XYL by listing it as a “Outperform.” The predicted price for XYL in the upcoming period, according to Exane BNP Paribas is $150 based on the research report published on March 12, 2024 of the current year 2024.
Wolfe Research gave a rating of “Outperform” to XYL, setting the target price at $127 in the report published on December 13th of the previous year.
XYL Trading at -1.37% from the 50-Day Moving Average
After a stumble in the market that brought XYL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.31% of loss for the given period.
Volatility was left at 2.14%, however, over the last 30 days, the volatility rate increased by 2.55%, as shares surge +4.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.12% lower at present.
During the last 5 trading sessions, XYL fell by -2.79%, which changed the moving average for the period of 200-days by +48.10% in comparison to the 20-day moving average, which settled at $137.28. In addition, Xylem Inc saw 19.67% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at XYL starting from McShane Geri-Michelle, who sale 2,278 shares at the price of $138.63 back on Jun 10 ’24. After this action, McShane Geri-Michelle now owns 3,536 shares of Xylem Inc, valued at $315,799 using the latest closing price.
Aulick Rodney, the SVP & President, WSS of Xylem Inc, sale 21,800 shares at $139.01 during a trade that took place back on Jun 05 ’24, which means that Aulick Rodney is holding 76,287 shares at $3,030,387 based on the most recent closing price.
Stock Fundamentals for XYL
Current profitability levels for the company are sitting at:
- 0.09 for the present operating margin
- 0.37 for the gross margin
The net margin for Xylem Inc stands at 0.08. The total capital return value is set at 0.05. Equity return is now at value 9.63, with 5.56 for asset returns.
Based on Xylem Inc (XYL), the company’s capital structure generated 0.19 points at debt to capital in total, while cash flow to debt ratio is standing at 0.4. The debt to equity ratio resting at 0.23. The interest coverage ratio of the stock is 11.87.
Currently, EBITDA for the company is 1.17 billion with net debt to EBITDA at 1.27. When we switch over and look at the enterprise to sales, we see a ratio of 4.34. The receivables turnover for the company is 4.84for trailing twelve months and the total asset turnover is 0.5. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.67.
Conclusion
To wrap up, the performance of Xylem Inc (XYL) has been better in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
